Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
sanofi
3
×
biotech
boston
clinical trials
national top stories
new york blog main
new york top stories
alirocumab
allosteric
alnylam pharmaceuticals
amgen
atlas venture
atopic dermatitis
autoimmune disorders
biontech
boehringer ingelheim
brace pharma
cleva pharma
curevac
drug discovery
dupilumab
eli lilly
evolocumab
fda
glaxosmithkline
hotspot therapeutics
inclisiran
infectious diseases
investing
john shiver
jonathan montagu
metabolic diseases
moderna therapeutics
mrl ventures fund
mrna
What
medicines
new
3
×
deal
molecules
acquire
address
adds
ago
agreed
allosteric
bets
billion
bio
brings
cancer
cash
cholesterol
clinic
comes
companies
company
compound
cut
date
disease
drug
effective
elusive
enticed
evidence
fda
hasn’t
hotspot
latest
medco
messenger
mrna
multiple
novartis
path
Language
unset
Current search:
sanofi
×
deals
×
new
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines